Researchers have developed an AI model called SyntheMol that can design entirely new molecules, including potential antibiotics. This model has generated six novel drugs aimed at killing resistant strains of Acinetobacter baumannii, one of the leading pathogens responsible for antibacterial resistance-related deaths. These new compounds have shown promise in fighting other infectious bacteria as well, including E. coli, MRSA, and those that can cause meningitis and pneumonia.